LINK Medical supports Isofol following regulatory approval of optimized Phase Ib/II study design
Ribo Submits Phase 2b Clinical Trial Application for world’s first siRNA FXI inhibitor in atrial fibrillation
Strengthening the link from CMC to clinic
Choosing the Best Oral Dosage Form for Your First-in-Human (FIH) Clinical Trial
Aplagon Doses First Patient in Phase 2a ‘HEALING’ Trial of APAC in PAOD/CLTI
Nordic Regulatory Services – Local Presence and Expertise
Accelerated National Clinical Trial Pathway in Finland
On track to meet the deadline for Vet QRD 9.1 update?
OncoZenge Submits Clinical Trial Application for Pivotal Phase III Trial (BZ003) of BupiZenge™
How LINK Medical, BSI, and Viedoc Enable Smarter Real-World Trials
Contact us and we will tell you more
Search the site
Search on LINK Medical